The results indicate that miR-4455 is a novel regulatory miRNA that targets VASP in gastric cancer cells, and suggest that the miR-4455-VASP-PI3K/AKT axis offers potential as a novel therapeutic target for the inhibition of gastric cancer progression and metastasis. The gene discussed is AKT1; the disease is gastric cancer.